<table id="id_4fa5e46b-ae9f-49ce-926b-6fd8c0432548" width="692.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_fba89bf7-a82c-4e76-9238-c2e3f9e0cb18">Table 9. Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablet Dose is 8 to 20% Higher</caption>
<col width="30.2%"></col>
<col width="29.3%"></col>
<col width="14.3%"></col>
<col width="13.4%"></col>
<col width="12.7%"></col>
<tbody>
<tr id="id_1f256aef-360f-4194-a75f-84fc8820e286">
<td align="left" rowspan="2" stylecode="Botrule Toprule Rrule" valign="top">
<content stylecode="bold">
<br/>
<br/>Study Population</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Regimens</content>
</td>
<td align="left" colspan="3" stylecode="Botrule" valign="top">
<content stylecode="bold">Relative Bioavailability</content>
</td>
</tr>
<tr id="id_be8bb674-4507-44f3-bc39-58b765fe042f">
<td align="left" stylecode="Botrule Rrule" valign="top">Divalproex Sodium Extended-Release Tablets vs. Divalproex Sodium Delayed-Release Tablets</td>
<td align="left" stylecode="Botrule Rrule" valign="top">AUC<sub>24</sub>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">C<sub>max</sub>
</td>
<td align="left" stylecode="Botrule" valign="top">C<sub>min</sub>
</td>
</tr>
<tr id="id_44a723a2-4d31-43de-97a1-adff14861bad">
<td align="left" stylecode="Botrule Rrule" valign="top">Healthy Volunteers (N = 35)</td>
<td align="left" stylecode="Botrule Rrule" valign="top">1000 &amp; 1500 mg Divalproex sodium extended-release tabletsvs. 875 &amp; 1250 mg Divalproex sodium delayed-release tablets</td>
<td align="left" stylecode="Botrule Rrule" valign="top">1.059</td>
<td align="left" stylecode="Botrule Rrule" valign="top">0.882</td>
<td align="left" stylecode="Botrule" valign="top">1.173</td>
</tr>
<tr id="id_c52452d7-2f56-4ac4-a9d0-d98be91bae8d">
<td align="left" stylecode="Botrule Rrule" valign="top">Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs (N = 64)</td>
<td align="left" stylecode="Rrule" valign="top">1000 to 5000 mg Divalproex sodium extended-release tablets vs. 875 to 4250 mg Divalproex Sodium delayed-release tablets</td>
<td align="left" stylecode="Rrule" valign="top">1.008</td>
<td align="left" stylecode="Rrule" valign="top">0.899</td>
<td align="left" stylecode="Botrule" valign="top">1.022</td>
</tr>
</tbody>
</table>